Evidence map›Paper›PMID 38327861›Full record

ArticleJournal of food science and technology2024

Obtaining and evaluating of enzymatic extracts from hairless canary seed (CDC Maria) as gluten-free bread-improving agents.

E Dios Sanz, T Sanmartino, M E Campderrós, L T Rodriguez Furlán

Abstract read
In one paragraph

Article in Journal of food science and technology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

E Dios SanzResearch Institute of Chemical Technology (INTEQUI)-CONICET, Faculty of Chemistry, Biochemistry and Pharmacy (UNSL), Ejército de los Andes 950, San Luis, Argentina.
T SanmartinoResearch Institute of Chemical Technology (INTEQUI)-CONICET, Faculty of Chemistry, Biochemistry and Pharmacy (UNSL), Ejército de los Andes 950, San Luis, Argentina.
M E CampderrósResearch Institute of Chemical Technology (INTEQUI)-CONICET, Faculty of Chemistry, Biochemistry and Pharmacy (UNSL), Ejército de los Andes 950, San Luis, Argentina.
L T Rodriguez FurlánResearch Institute of Chemical Technology (INTEQUI)-CONICET, Faculty of Chemistry, Biochemistry and Pharmacy (UNSL), Ejército de los Andes 950, San Luis, Argentina.ORCID 0000-0002-0515-8873

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, enzyme extracts were obtained from hairless canary seeds (CDC Maria) and used as gluten-free bread improvers. The enzyme extraction was done with a specific protein buffer solution and subsequent centrifugation. The supernatant was called crude enzyme extract, a fraction of this extract was refrigerated (CE) and another fraction was lyophilized (CEL). The lyoprotective effect of corn fiber (CEL + CF), maltodextrin (CEL + M), and inulin (CEL + I) was evaluated. Each enzyme extract was added to a gluten-free bread at 0.25%, 0.5%, 0.75% and 1% (w/w). The quality of the gluten-free bread was determined by external and internal characteristically, physical and sensory analysis: analysis of the lamella thickness, the shape factor of pores, the final volume, the aeration percentage, the texture profile analysis, the pore size distribution and shelf-life time. The results showed that the formulation with CEL at 0.5% (w/w) significantly improved the gluten-free bread quality properties, generating an increase of the final volume and aeration percentage, a reduction of the firmness, chewiness and sample aging, and a finer and more uniform crumb structure when compared to a control sample (

Indexed as

Food enzymesGluten-free bread improving agentHairless canary seedLyoprotective agents

Identifiers

PMID38327861
PMCPMC10844167

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.